The right probiotic depends entirely on what you’re trying to address. There is no single “best” strain for everyone. Probiotics are strain-specific, meaning the exact organism matters far more than the brand name or the billion-count number on the label. A strain that helps with antibiotic-related diarrhea may do nothing for bloating, and one studied for mood may have no effect on digestion.
Here’s what the clinical evidence actually supports for the most common reasons people reach for a probiotic.
If You’re Taking Antibiotics
This is the strongest use case for probiotics. Two strains stand out for preventing the diarrhea that antibiotics commonly cause: Lactobacillus rhamnosus GG (often labeled LGG) and Saccharomyces boulardii. Saccharomyces boulardii is actually a yeast, not a bacterium, which means antibiotics won’t kill it while you’re taking them. That’s a practical advantage.
Effective doses in clinical trials typically range from 5 to 40 billion CFU per day. But even lower doses under 5 billion CFU showed benefit in preventing antibiotic-associated diarrhea, though you’d need to treat about 9 people to prevent one case at that dose compared to fewer at higher doses. For children specifically, 10 to 20 billion CFU per day of LGG reduced the risk of antibiotic-associated diarrhea by 71%.
Start taking the probiotic at the same time you begin your antibiotic course and continue for at least the full duration of the prescription. Space them a few hours apart so the antibiotic doesn’t immediately destroy the probiotic bacteria (this doesn’t apply to S. boulardii, since antibiotics don’t affect yeast).
If You Have IBS or Digestive Issues
Irritable bowel syndrome is where probiotic marketing gets ahead of the science. You’ll see Bifidobacterium infantis 35624 recommended frequently, but a systematic review in The Lancet’s eClinicalMedicine found the evidence is more complicated than supplement labels suggest. In one well-designed trial, a medium dose of B. infantis 35624 showed improvement in abdominal pain and bloating (62% of participants improved versus 42% on placebo), but the high dose didn’t outperform placebo. LGG showed a trend toward reducing abdominal pain in IBS but didn’t reach statistical significance.
The honest takeaway: some people with IBS do respond to specific probiotics, but results are inconsistent across studies. If you want to try one, B. infantis 35624 or LGG are reasonable starting points based on the available data. Give it at least four weeks before deciding whether it’s helping.
If You Want Mood or Stress Support
The connection between gut bacteria and brain function is real, though still early in clinical terms. A combination of Lactobacillus helveticus R0052, Bifidobacterium longum R0175, and Lactiplantibacillus plantarum R1012 (totaling 3 billion CFU per day) was tested in a randomized, placebo-controlled crossover study with healthy adults. After four weeks, brain imaging showed altered activity in regions involved in emotional processing and regulation compared to the placebo period.
This doesn’t mean probiotics treat anxiety or depression. But it does suggest that specific strains can measurably influence how the brain handles emotional tasks, even in healthy people. If you’re curious about this category, look for products containing these exact strains rather than generic “mood support” blends.
If You’re Looking for Metabolic Support
Akkermansia muciniphila is a newer entrant to the probiotic market, positioned for weight management and blood sugar control. A 12-week randomized trial in people with type 2 diabetes and overweight found that the supplement reduced body weight, fat mass, and a key blood sugar marker, but only in participants who had low levels of Akkermansia in their gut to begin with. People who already had high baseline levels saw poor colonization and no clinical improvement.
This is an important pattern that applies broadly: probiotics tend to work best when you’re low in what you’re supplementing. There’s currently no easy way to know your baseline Akkermansia levels without specialized gut microbiome testing, which limits how useful this finding is in practice.
For Vaginal and Urinary Health
Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 are the two strains most marketed for vaginal health. However, a randomized controlled trial that added these strains (taken orally at 1 billion CFU per day for 30 days) to standard antibiotic treatment for bacterial vaginosis found no improvement in cure rates. The 30-day cure rate was nearly identical between the probiotic-plus-antibiotic group (58%) and the antibiotic-only group (60%).
One likely reason: the probiotic species were rarely detected in either vaginal or fecal samples after oral administration, suggesting the bacteria simply didn’t survive the journey or establish themselves. Oral probiotics for vaginal health remain a popular idea with limited clinical support.
For Children With Eczema
One of the more promising probiotic applications involves skin health in children. An NIH-supported study tested a bacterium called Roseomonas mucosa, applied directly to the skin of 20 children (ages 3 to 16) with mild to severe eczema. Seventeen of the 20 children experienced greater than 50% improvement in eczema severity. The treated skin showed increased microbial diversity and reduced levels of Staphylococcus aureus, a bacterium that worsens eczema flares. This is a topical probiotic rather than an oral supplement, and it’s still in clinical trial stages rather than widely available.
How to Read a Probiotic Label
Three things matter on the label, in this order:
- Strain designation: The full name should include genus, species, and strain number. “Lactobacillus rhamnosus” alone tells you almost nothing. “Lactobacillus rhamnosus GG” tells you it’s the specific strain with clinical evidence. If a product only lists genus and species without a strain code, it hasn’t been matched to any particular study.
- CFU count at expiration: Some labels list CFU “at time of manufacture,” which is meaningless since bacteria die during storage. Look for a guaranteed count through the expiration date. Most supplements contain 1 to 10 billion CFU per dose, and higher counts are not necessarily more effective.
- Storage requirements: Freeze-dried probiotics are processed to remain stable at room temperature by removing water and putting organisms into a dormant state. Some strains are too sensitive to survive this process and require refrigeration. Neither format is inherently better, but if a product says “refrigerate after opening,” keeping it on your bathroom counter will reduce potency. Capsules generally protect bacteria better than chewable tablets, since the pressure used to create chewables can damage organisms.
Third-Party Testing Matters
Probiotics are regulated as dietary supplements, which means manufacturers don’t need to prove their products work before selling them. Independent testing has repeatedly found products with fewer live organisms than claimed or with species not listed on the label.
The USP Verified Mark is the most rigorous third-party certification available. It verifies that the product contains what the label says, doesn’t have harmful levels of contaminants like heavy metals or pesticides, will actually break down and release its contents for absorption, and was manufactured under controlled, sanitary conditions with batch-to-batch consistency. NSF International and ConsumerLab also run independent testing programs. Any of these seals on a probiotic label significantly increases the odds that you’re getting what you paid for.
Matching the Strain to Your Goal
If this feels overwhelming, here’s a practical framework. Identify your primary reason for taking a probiotic, then look for the specific strain studied for that purpose. For antibiotic recovery, that’s LGG or S. boulardii at 5 billion CFU or more per day. For IBS symptoms, try B. infantis 35624 at a moderate dose. For general gut-brain interest, look for L. helveticus R0052 and B. longum R0175 together.
Avoid multi-strain blends that list 15 or 20 organisms with no rationale for the combination. More strains doesn’t mean broader benefit. It often means the product was designed to look impressive on a label rather than to match any clinical evidence. A single well-studied strain at an effective dose will almost always outperform a scattershot blend.